http://www.legislation.gov.uk/uksi/2016/583/article/2/madeThe Prison and Young Offender Institution (Amendment) Rules 2016enKing's Printer of Acts of Parliament2017-08-16PRISONS, ENGLAND AND WALESYOUNG OFFENDER INSTITUTIONS, ENGLAND AND WALESThese Rules amend the Prison Rules 1999 (S.I. 1999/728) (“the 1999 Rules”) and the Young Offender Institution Rules 2000 (S.I. 2000/3371) (“the 2000 Rules”). These Rules specify substances or products which are “specified drugs” for the purposes of section 16A (testing prisoners for drugs) of the Prison Act 1952 (c. 52) (“the Act”). The effect of section 16A of the Act is that a prison officer can require a prisoner or an inmate to provide a sample for the purposes of ascertaining whether there is a specified drug in the body of the prisoner or inmate. The effect of the amendments to rules 2 and 50 (compulsory testing for controlled drugs) of the 1999 Rules and rules 2 and 53 (compulsory testing for controlled drugs) of the 2000 Rules is to list the specified drugs and provide for compulsory testing of those specified drugs.Amendment of the Prison Rules 19992.(1)

The Prison Rules 1999

S.I. 1999/728.

are amended as follows.

(2)

In rule 2(1) (interpretation)

Amended by S.I. 2000/2641, 2003/3301, 2005/869, 2005/3437, 2008/597, 2009/3082, 2013/235, 2014/2169.

, after the definition of “prison minister” insert—

“specified drug” means any product or substance containing—

(a)

AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide);

(b)

5F-AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-Fluoropentyl)-1H-indazole-3-carboxamide);

(c)

AB-FUBINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide);

(d)

APICA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide);

(e)

5F-APICA (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide);

(f)

APINACA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(g)

5F-APINACA (1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(h)

5F-PB22 (1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid), and

(i)

MDMB-CHMICA (methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate);

.

(3)

In the heading to rule 50 (compulsory testing for controlled drugs), after “controlled drugs” insert “or specified drugs”.

(4)

In rule 50(1), after “controlled drug” insert “or specified drug”.

(5)

In rule 51 (offences against discipline)

Amended by S.I. 2005/869; there are other amending instruments but none is relevant.

, after “controlled drug”, in both places it occurs, insert “or specified drug”.

(6)

In rule 52 (defences to rule 51(9)), after “controlled drug”, wherever it appears, insert “or specified drug”.

This XML file does not appear to have any style information associated with it. The document tree is shown below.
<akomaNtoso xmlns:uk="https://www.legislation.gov.uk/namespaces/UK-AKN" xmlns:ukl="http://www.legislation.gov.uk/namespaces/legislation" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0" xsi:schemaLocation="http://docs.oasis-open.org/legaldocml/ns/akn/3.0 http://docs.oasis-open.org/legaldocml/akn-core/v1.0/cos01/part2-specs/schemas/akomantoso30.xsd">
<act name="uksi">
<meta>
<identification source="#">
<FRBRWork>
<FRBRthis value="http://www.legislation.gov.uk/id/uksi/2016/583"/>
<FRBRuri value="http://www.legislation.gov.uk/id/uksi/2016/583"/>
<FRBRdate date="2016-05-11" name="made"/>
<FRBRauthor href="http://www.legislation.gov.uk/id/government/uk"/>
<FRBRcountry value="GB-UKM"/>
<FRBRsubtype value="rule"/>
<FRBRnumber value="583"/>
<FRBRname value="S.I. 2016/583"/>
<FRBRprescriptive value="true"/>
</FRBRWork>
<FRBRExpression>
<FRBRthis value="http://www.legislation.gov.uk/uksi/2016/583/made"/>
<FRBRuri value="http://www.legislation.gov.uk/uksi/2016/583/made"/>
<FRBRdate date="2016-05-11" name="made"/>
<FRBRauthor href="#"/>
<FRBRlanguage language="eng"/>
</FRBRExpression>
<FRBRManifestation>
<FRBRthis value="http://www.legislation.gov.uk/uksi/2016/583/made/data.akn"/>
<FRBRuri value="http://www.legislation.gov.uk/uksi/2016/583/made/data.akn"/>
<FRBRdate date="2024-11-30Z" name="transform"/>
<FRBRauthor href="http://www.legislation.gov.uk"/>
<FRBRformat value="application/akn+xml"/>
</FRBRManifestation>
</identification>
<lifecycle source="#">
<eventRef refersTo="#made" date="2016-05-11" eId="date-made" source="#"/>
<eventRef refersTo="#laid" date="2016-05-16" eId="date-laid-1" source="#united-kingdom-parliament"/>
<eventRef refersTo="#coming-into-force" date="2016-06-07" eId="date-cif-1" source="#"/>
</lifecycle>
<analysis source="#">
<otherAnalysis source=""/>
</analysis>
<references source="#">
<TLCOrganization eId="united-kingdom-parliament" href="" showAs="UnitedKingdomParliament"/>
<TLCEvent eId="made" href="" showAs="Made"/>
<TLCEvent eId="laid" href="" showAs="Laid"/>
<TLCEvent eId="cif" href="" showAs="ComingIntoForce"/>
</references>
<proprietary xmlns:ukm="http://www.legislation.gov.uk/namespaces/metadata" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" source="#">
<dc:identifier>http://www.legislation.gov.uk/uksi/2016/583/article/2/made</dc:identifier>
<dc:title>The Prison and Young Offender Institution (Amendment) Rules 2016</dc:title>
<dc:language>en</dc:language>
<dc:publisher>King's Printer of Acts of Parliament</dc:publisher>
<dc:modified>2017-08-16</dc:modified>
<dc:subject scheme="SIheading">PRISONS, ENGLAND AND WALES</dc:subject>
<dc:subject scheme="SIheading">YOUNG OFFENDER INSTITUTIONS, ENGLAND AND WALES</dc:subject>
<dc:description>These Rules amend the Prison Rules 1999 (S.I. 1999/728) (“the 1999 Rules”) and the Young Offender Institution Rules 2000 (S.I. 2000/3371) (“the 2000 Rules”). These Rules specify substances or products which are “specified drugs” for the purposes of section 16A (testing prisoners for drugs) of the Prison Act 1952 (c. 52) (“the Act”). The effect of section 16A of the Act is that a prison officer can require a prisoner or an inmate to provide a sample for the purposes of ascertaining whether there is a specified drug in the body of the prisoner or inmate. The effect of the amendments to rules 2 and 50 (compulsory testing for controlled drugs) of the 1999 Rules and rules 2 and 53 (compulsory testing for controlled drugs) of the 2000 Rules is to list the specified drugs and provide for compulsory testing of those specified drugs.</dc:description>
<ukm:SecondaryMetadata>
<ukm:DocumentClassification>
<ukm:DocumentCategory Value="secondary"/>
<ukm:DocumentMainType Value="UnitedKingdomStatutoryInstrument"/>
<ukm:DocumentStatus Value="final"/>
<ukm:DocumentMinorType Value="rule"/>
</ukm:DocumentClassification>
<ukm:Year Value="2016"/>
<ukm:Number Value="583"/>
<ukm:Made Date="2016-05-11"/>
<ukm:Laid Date="2016-05-16" Class="UnitedKingdomParliament"/>
<ukm:ComingIntoForce>
<ukm:DateTime Date="2016-06-07"/>
</ukm:ComingIntoForce>
<ukm:ISBN Value="9780111146897"/>
</ukm:SecondaryMetadata>
<ukm:Notes>
<ukm:Note IdURI="http://www.legislation.gov.uk/id/uksi/2016/583/notes"/>
<ukm:Alternatives>
<ukm:Alternative URI="http://www.legislation.gov.uk/uksi/2016/583/pdfs/uksiem_20160583_en.pdf" Date="2016-05-16" Title="UK Explanatory Memorandum" Size="37246"/>
</ukm:Alternatives>
</ukm:Notes>
<ukm:Alternatives>
<ukm:Alternative URI="http://www.legislation.gov.uk/uksi/2016/583/pdfs/uksi_20160583_en.pdf" Date="2016-05-16" Size="38342"/>
</ukm:Alternatives>
<ukm:Statistics>
<ukm:TotalParagraphs Value="3"/>
<ukm:BodyParagraphs Value="3"/>
<ukm:ScheduleParagraphs Value="0"/>
<ukm:AttachmentParagraphs Value="0"/>
<ukm:TotalImages Value="0"/>
</ukm:Statistics>
</proprietary>
</meta>
<body>
<rule eId="article-2" uk:target="true">
<heading>Amendment of the Prison Rules 1999</heading>
<num>2.</num>
<paragraph eId="article-2-1">
<num>(1)</num>
<content>
<p>
The Prison Rules 1999
<authorialNote class="footnote" eId="f00002" marker="2">
<p>
<ref eId="c00008" href="http://www.legislation.gov.uk/id/uksi/1999/728">S.I. 1999/728</ref>
.
</p>
</authorialNote>
are amended as follows.
</p>
</content>
</paragraph>
<paragraph eId="article-2-2">
<num>(2)</num>
<content>
<p>
<mod>
In rule 2(1) (interpretation)
<authorialNote class="footnote" eId="f00003" marker="3">
<p>
Amended by
<ref eId="c00009" href="http://www.legislation.gov.uk/id/uksi/2000/2641">S.I. 2000/2641</ref>
,
<ref eId="c00010" href="http://www.legislation.gov.uk/id/uksi/2003/3301">2003/3301</ref>
,
<ref eId="c00011" href="http://www.legislation.gov.uk/id/uksi/2005/869">2005/869</ref>
,
<ref eId="c00012" href="http://www.legislation.gov.uk/id/uksi/2005/3437">2005/3437</ref>
,
<ref eId="c00013" href="http://www.legislation.gov.uk/id/uksi/2008/597">2008/597</ref>
,
<ref eId="c00014" href="http://www.legislation.gov.uk/id/uksi/2009/3082">2009/3082</ref>
,
<ref eId="c00015" href="http://www.legislation.gov.uk/id/uksi/2013/235">2013/235</ref>
,
<ref eId="c00016" href="http://www.legislation.gov.uk/id/uksi/2014/2169">2014/2169</ref>
.
</p>
</authorialNote>
, after the definition of “prison minister” insert—
<quotedStructure startQuote="" endQuote="" uk:context="unknown" uk:docName="unknown" ukl:TargetClass="unknown" ukl:TargetSubClass="unknown" ukl:Context="unknown" ukl:Format="double">
<hcontainer name="definition">
<intro>
<p>“specified drug” means any product or substance containing—</p>
</intro>
<level class="para1">
<num>(a)</num>
<content>
<p>AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide);</p>
</content>
</level>
<level class="para1">
<num>(b)</num>
<content>
<p>5F-AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-Fluoropentyl)-1H-indazole-3-carboxamide);</p>
</content>
</level>
<level class="para1">
<num>(c)</num>
<content>
<p>AB-FUBINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide);</p>
</content>
</level>
<level class="para1">
<num>(d)</num>
<content>
<p>
APICA (1-pentyl-N-tricyclo[3.3.1.1
<sup>3,7</sup>
]dec-1-yl-1H-indole-3-carboxamide);
</p>
</content>
</level>
<level class="para1">
<num>(e)</num>
<content>
<p>5F-APICA (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide);</p>
</content>
</level>
<level class="para1">
<num>(f)</num>
<content>
<p>
APINACA (1-pentyl-N-tricyclo[3.3.1.1
<sup>3,7</sup>
]dec-1-yl-1H-indazole-3-carboxamide);
</p>
</content>
</level>
<level class="para1">
<num>(g)</num>
<content>
<p>
5F-APINACA (1-(5-fluoropentyl)-N-tricyclo[3.3.1.1
<sup>3,7</sup>
]dec-1-yl-1H-indazole-3-carboxamide);
</p>
</content>
</level>
<level class="para1">
<num>(h)</num>
<content>
<p>5F-PB22 (1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid), and</p>
</content>
</level>
<level class="para1">
<num>(i)</num>
<content>
<p>MDMB-CHMICA (methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate);</p>
</content>
</level>
</hcontainer>
</quotedStructure>
<inline name="appendText">.</inline>
</mod>
</p>
</content>
</paragraph>
<paragraph eId="article-2-3">
<num>(3)</num>
<content>
<p>In the heading to rule 50 (compulsory testing for controlled drugs), after “controlled drugs” insert “or specified drugs”.</p>
</content>
</paragraph>
<paragraph eId="article-2-4">
<num>(4)</num>
<content>
<p>In rule 50(1), after “controlled drug” insert “or specified drug”.</p>
</content>
</paragraph>
<paragraph eId="article-2-5">
<num>(5)</num>
<content>
<p>
In rule 51 (offences against discipline)
<authorialNote class="footnote" eId="f00004" marker="4">
<p>
Amended by
<ref eId="c00017" href="http://www.legislation.gov.uk/id/uksi/2005/869">S.I. 2005/869</ref>
; there are other amending instruments but none is relevant.
</p>
</authorialNote>
, after “controlled drug”, in both places it occurs, insert “or specified drug”.
</p>
</content>
</paragraph>
<paragraph eId="article-2-6">
<num>(6)</num>
<content>
<p>In rule 52 (defences to rule 51(9)), after “controlled drug”, wherever it appears, insert “or specified drug”.</p>
</content>
</paragraph>
</rule>
</body>
</act>
</akomaNtoso>